Further studies of the mechanisms by which Cdk1 and Cdk2 are involved in the plasticity of prostate cancer cells are necessary based on the fact that different approaches to the modulation of their expression and activity were not uniformly reflected in terms of NED promotion. The gene discussed is CDK2; the disease is Familial prostate cancer.